159 related articles for article (PubMed ID: 38323765)
21. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
Dahmani O; Sophoclis C; Kebir M; Bouguern D; Sakho A; Demarchi P
Saudi J Kidney Dis Transpl; 2017; 28(1):154-157. PubMed ID: 28098117
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
[TBL] [Abstract][Full Text] [Related]
23. Humoral hypercalcemia of pregnancy treated with bisphosphonates.
Koren R; Neeman O; Koren S; Benbassat CA
Arch Endocrinol Metab; 2018 Feb; 62(1):125-128. PubMed ID: 29694631
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
25. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
El-Hajj Fuleihan G; Clines GA; Hu MI; Marcocci C; Murad MH; Piggott T; Van Poznak C; Wu JY; Drake MT
J Clin Endocrinol Metab; 2023 Feb; 108(3):507-528. PubMed ID: 36545746
[TBL] [Abstract][Full Text] [Related]
27. [Hypercalcemia (with treatment)].
Prié D
Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
[No Abstract] [Full Text] [Related]
28. [The medical treatment of primary hyperparathyroidism].
Lo Cascio V; Rossini M; Bertoldo F
Recenti Prog Med; 1993 Apr; 84(4):287-95. PubMed ID: 8488334
[TBL] [Abstract][Full Text] [Related]
29. Denosumab in hypercalcemia of malignancy: a case series.
Dietzek A; Connelly K; Cotugno M; Bartel S; McDonnell AM
J Oncol Pharm Pract; 2015 Apr; 21(2):143-7. PubMed ID: 24415364
[TBL] [Abstract][Full Text] [Related]
30. Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.
Pyram R; Mahajan G; Gliwa A
Maturitas; 2011 Nov; 70(3):246-55. PubMed ID: 21943558
[TBL] [Abstract][Full Text] [Related]
31. [Hypercalcemia].
Matikainen N
Duodecim; 2014; 130(14):1404-12. PubMed ID: 25158579
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy.
Maier JD; Levine SN
J Intensive Care Med; 2015 Jul; 30(5):235-52. PubMed ID: 24130250
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia: an evidence-based approach to clinical cases.
Assadi F
Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781
[TBL] [Abstract][Full Text] [Related]
34. Cancer-related hypercalcemia and potential treatments.
Almuradova E; Cicin I
Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
[TBL] [Abstract][Full Text] [Related]
35. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
36. Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
Zhang P; Yu Y; Gao Y; Yuan G; Zhang J; Wang W
Hemodial Int; 2023 Apr; 27(2):E23-E28. PubMed ID: 36719850
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Leyland-Jones B
Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
[TBL] [Abstract][Full Text] [Related]
38. Etiology and current management of cancer-related hypercalcemia.
Warrell RP
Oncology (Williston Park); 1992 Oct; 6(10):37-43; discussion 43, 47-50. PubMed ID: 1390013
[TBL] [Abstract][Full Text] [Related]
39. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
40. Calcium metabolism & hypercalcemia in adults.
Lumachi F; Motta R; Cecchin D; Ave S; Camozzi V; Basso SM; Luisetto G
Curr Med Chem; 2011; 18(23):3529-36. PubMed ID: 21756230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
